|
Description:
|
|
In this episode of Drugs n Stuff, Dave Crosland and Scott McNally discuss how FDA warning letters, peptide crackdowns, and supply disruptions are reshaping the steroid and PED market heading into 2026. They also answer listener questions on TRT, cycle design, estrogen management, and compound selection as the landscape continues to evolve. 0:00 Dianabol “Breakfast of Champions” 0:45 DNS Podcast 277 – Dave Crosland & Scott McNally 1:45 Arnold UK Discussion 4:15 PED Market Changes for 2026 8:45 FDA Warning Letters & Peptide Prosecution 11:45 How the Peptide Market Will Change 14:40 Is the Anabolic Market Recovering? 19:30 Underground GH Market 20:55 Scott’s Shirt 23:40 Dopamine, P5P & Dave’s Mistake 32:40 Controlling Estrogen Based on Labs 36:40 DHB Shot Pain & Carrier Oils 37:35 Iron & Ferritin Deficiency 43:00 Test-Only Cruise vs Adding Compounds 45:55 Profiling MENT 52:00 Building Muscle on 200mg TRT 53:00 Best Stack for the New Year 55:20 Uncle Dave’s Wisdom 1:05:55 Behind the Scenes – Dave’s Vacation |